The Bluefield Innovations vehicle will back early-stage Johns Hopkins projects over five years with a view to eventually spinning out or licensing promising ideas.
Johns Hopkins University joined forces with US-based healthcare investment firm Deerfield Management yesterday to launch a $65m commercialisation fund called Bluefield Innovations aimed at the university’s therapeutic research.
The vehicle will be funded by Deerfield and will spend its initial $65m budget on early-stage projects over five years. Additional capital may be found for projects that demonstrate likely market potential.
A joint steering committee will identify what projects should receive Bluefield backing, and promising research could eventually be licensed to…
